NCT05031962

Safety and Clinical Performance of a Biological Matrix Used in Implant-based Breast Reconstruction

Porcine Acellular Dermal Matrix (PADM)-Assisted Implant-based Breast Reconstruction: a Prospective Observational Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 112 (actual)
• Sponsor: Meccellis Biotech · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The general objective of the study is to confirm the medium/long-term safety and clinical performance of the CELLIS Breast membranes used in breast reconstruction and to identify emerging risks in comparison to clinical data related to other treatment modalities. The present study will be a prospective, multicentric, non-randomized and non-controlled trial involving 112 patients followed for 24 months. The study will be conducted in France in 7 investigational centres.

Detailed description

The study will be prospective, multicentric, single-arm observational (non-interventional) to evaluate the safety and performance of the CELLIS Breast membranes used in breast reconstruction following mastectomy. All evaluations will be performed and products used according to the usual practice, without additional or unusual diagnostic, treatment and monitoring procedure. The study will be conducted in France in 7 investigational centres including 112 patients scheduled for a breast reconstruction following mastectomy. Each patient will participate in one assessment period including a preoperative visit, followed by the day of surgical procedure and a hospitalization period. Patients will return for ambulatory visits on day 10 (+/- 5 days) and/or on day 30 (+/- 7 days), on month 3 (+/- 2 weeks), on month 12 (+/- 2 weeks) and on month 24 (+/-2 weeks) post-surgery. CELLIS Breast is available in one thickness, in a variety of size and forms addressing multiple surgical techniques.

Conditions

• Breast Reconstruction Following Mastectomy

Interventions

Type	Name	Description
DEVICE	CELLIS Breast (Porcine Acellular Dermal Matrix, PADM)	Biological membrane used in breast reconstruction

Timeline

• Start date: 2021-10-04
• Primary completion: 2026-10-01
• Completion: 2026-10-01
• First posted: 2021-09-02
• Last updated: 2024-11-22

Locations

10 sites across 1 country: France